Endo, Actavis Settle Spat Over Painkiller Patents

Law360, New York (February 19, 2009, 12:00 AM EST) -- Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co. have reached a settlement with Actavis South Atlantic LLC in a patent infringement suit over Actavis' attempt to make and market a generic version of pain medication Opana ER.

Judge Katharine S. Hayden of the U.S. District Court for the District of New Jersey on Wednesday signed an order dismissing the action without prejudice and without costs, subject to the right of the parties to reopen the case if the settlement is not consummated within 60 days.

Additional details...
To view the full article, register now.